Human Metabolome Technologies, Inc. (TSE: 6090)
Health Care · Life Sciences Tools & Services · JP
¥604.00
-0.33% today · -15.4% 1Y
Human Metabolome Technologies, Inc. (TSE: 6090) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $21.22M and employs 65 people.
Over the last twelve months the share price has lost 15.4%, trading between 570.00 and 766.00.
Tweenvest scores Human Metabolome Technologies, Inc. across four factors: quality 82/100, value 67/100, growth 0/100, dividend 68/100. Its strongest factor is quality.
6090 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.22M
- Revenue (TTM)
- $8.74M
- P/E
- 16.95
- EPS
- 35.64
- Dividend yield
- 2.98%
- Beta (5Y)
- -0.05
- 52-week high
- ¥766.00
- 52-week low
- ¥570.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.56M
- Employees
- 65
- Next earnings
- —
About Human Metabolome Technologies, Inc.
Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
- ISIN
- JP3794530000
- Founded
- 2003
- Listed since
- Dec 24, 2013
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioLASCO Taiwan Co., Ltd.TPEX: 6662 | $22.96M | NT$28.50 | -0.35% |
| IXICO plcAIM: IXI | $22.46M | £0.08 | +3.33% |
| HyEnergy S.A.WSE: HEN | $21.40M | zł— | — |
| Brooks Laboratories LimitedNSEI: BROOKS | $21.35M | Rs70.13 | +27.97% |
| atect corporationTSE: 4241 | $20.21M | ¥724.00 | +1.54% |
| C&R Research Inc.KOSDAQ: A359090 | $19.88M | ₩2,325.00 | +1.97% |
| SLS BIO Co., LtdKOSDAQ: A246250 | $19.85M | ₩— | — |
| Genolution Inc.KOSDAQ: A225220 | $19.41M | ₩1,444.00 | -1.70% |
Figures last refreshed Oct 11, 2026.